Ebola virus – epidemiology, diagnosis, and control: threat to humans, lessons learnt, and preparedness plans – an update on its 40 year's journey

References

• Acquah C, Danquah MK, Agyei D, Moy CK, Sidhu A, Ongkudon CM. 2015. Deploying aptameric sensing technology for rapid pandemic monitoring. Crit Rev Biotechnol. 18:1–13.
   Google Scholar
• Ahmad N, Farman A, Badshah SL, Ur Rahman A, Ur Rashid H, Khan K. 2016. Molecular modeling, simulation and docking study of ebola virus glycoprotein. J Mol Graph Model. 19:266–271.
   Google Scholar
• Albarino CG, Shoemaker T, Khristova ML, Wamala JF, Muyembe JJ, Balinandi S, Tumusiime A, Campbell S, Cannon D, Gibbons A, et al. 2013. Genomic analysis of filoviruses associated with four viral hemorrhagic fever outbreaks in Uganda and the Democratic Republic of the Congo in 2012. Virology. 442:97–100.
   PubMed Web of Science ®Google Scholar
• Alimonti J, Leung A, Jones S, Gren J, Qiu X, Fernando L, Balcewich B, Wong G, Ströher U, Grolla A, et al. 2014. Evaluation of transmission risks associated with in vivo replication of several high containment pathogens in a biosafety level 4 laboratory. Sci Rep. 4:5824.
   PubMed Web of Science ®Google Scholar
• Allela L, Boury O, Pouillot R, Délicat A, Yab P, Kumulungui B, Rouquet P, Gonzalez JP, Leroy EM. 2005. Ebola virus antibody prevalence in dogs and human risk. Emerg Infect Dis. 11:385–390.
   PubMed Web of Science ®Google Scholar
• Amman BR, Jones ME, Sealy TK, Uebelhoer LS, Schuh AJ, Bird BH, Coleman-MacCray JD, Martin BE, Nichol ST, Towner JS. 2015. Oral shedding of Marburg virus in experimentally infected Egyptian fruit bats (Rousettus aegyptiacus). J Wildl Dis. 51:113–124.
   PubMed Web of Science ®Google Scholar
• Arntzen C. 2015. Plant-made pharmaceuticals: from “Edible Vaccines” to Ebola therapeutics. Plant Biotechnol. 13:1013–1016.
   Web of Science ®Google Scholar
• Arwady MA, Bawo L, Hunter JC, Massaquoi M, Matanock A, Dahn B, Ayscue P, Nyenshaw T, Forrester JD, Hensley LE, et al. 2015. Evolution of Ebola virus disease from exotic infection to global health priority, Liberia, mid-2014. Emerg Infect Dis. 21:578.
   PubMed Web of Science ®Google Scholar
• Ayukekbong JA. 2016. The 2014-2015 Ebola saga: lessons for the future. J Epidemiol Community Health. 70:1–2.
   PubMed Web of Science ®Google Scholar
• Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N, Soropogui B, Sow MS, Keita S, DeClerck H, et al. 2014. Emergence of Zaire Ebola virus disease in Guinea – preliminary report. N Engl J Med. 371:1418–1425.
   PubMed Web of Science ®Google Scholar
• Baker A. 2014. The race to diagnose. In S. O'Conner, editor. Time. Cape Town: Health Media Ventures; p. 28–29.
   Google Scholar
• Balmith M, Faya M, Soliman ME. 2016. Ebola virus: a gap in drug design and discovery – experimental and computational perspective. Chem Biol Drug Des. doi:10.1111/cbdd.12870.
   PubMed Web of Science ®Google Scholar
• Baron RC, McCormick JB, Zubeir OA. 1983. Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ. 61:997–1003.
   PubMed Web of Science ®Google Scholar
• Barrette RW, Metwally SA, Rowland JM, Xu L, Zaki SR, Nichol ST, Rollin PE, Towner JS, Shieh W-J, Batten B, et al. 2009. Discovery of swine as a host for the Reston ebolavirus. Science. 325:204–206.
   PubMed Web of Science ®Google Scholar
• Basler CF, Mikulasova A, Martinez-Sobrido L, Paragas J, Muhlberger E, Bray M, Klenk HD, Palese P, Garcia-Sastre A. 2003. The ebolavirus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol. 77:7945–7956.
   PubMed Web of Science ®Google Scholar
• Basler CF, Wang X, Muhlberger E, Volchkov V, Paragas J, Klenk HD, Garcia-Sastre A, Palese P. 2000. The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci USA. 97:12289–12294.
   PubMed Web of Science ®Google Scholar
• Basler CF. 2014. Portrait of a killer: genome of the 2014 EBOV outbreak strain. Cell Host Microbe. 16:419–421.
   PubMed Web of Science ®Google Scholar
• Bausch DG, Crozier I. 2016. The Liberia men's health screening program for Ebola virus: win-win-win for survivor, scientist, and public health. Lancet Glob Health. 4:e672–e673.
   PubMed Web of Science ®Google Scholar
• Bausch DG, Schwarz L. 2014. Outbreak of Ebola virus disease in Guinea: where ecology meets economy. PLoS Negl Trop Dis. 8:e3056.
   PubMed Web of Science ®Google Scholar
• Bausch DG, Towner JS, Dowell SF, Kaducu F, Lukwiya M, Sanchez A, Nichol ST, Ksiazek TG, Rollin PE. 2007. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis. 196:S142–S147.
   PubMed Web of Science ®Google Scholar
• Belak S, Thoren P, Le Blanc N, Viljoen G. 2009. Advances in viral disease diagnostic and molecular epidemiological technologies. Expert Rev Mol Diagn. 9:367–381.
   PubMed Web of Science ®Google Scholar
• Bellizzi S. 2014. The current Ebola outbreak: old and new contexts. J Infect Dev Ctries. 8:1378–1380.
   PubMed Web of Science ®Google Scholar
• Benowitz I, Ackelsberg J, Balter SE, Baumgartner JC, Dentinger C, Fine AD, Harper SA, Jones LE, Laraque F, Lee EH, et al. 2014. Centers for Disease Control and Prevention (CDC). Surveillance and preparedness for Ebola virus disease – New York City, 2014. MMWR Morb Mortal Wkly Rep. 63:934–936.
   PubMed Web of Science ®Google Scholar
• Benzine JW, Brown KM, Agans KN, Godiska R, Mire CE, Gowda K, Converse B, Geisbert TW, Mead DA, Chander Y. 2016. Molecular diagnostic field test for point-of-care detection of Ebola virus directly from blood. J Infect Dis. 214(S3):S234–242.
   PubMed Web of Science ®Google Scholar
• Bermejo M, Rodríguez-Teijeiro JD, Illera G, Barroso A, Vilà C, Walsh PD. 2006. Ebola outbreak killed 5000 gorillas. Science. 314:1564.
   PubMed Web of Science ®Google Scholar
• Bharat TAM, Noda T, Riches JD, Kraehling V, Kolesnikova L, Becker S, Kawaoka Y, Briggs JAG. 2012. Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography. Proc Natl Acad Sci USA. 109:4275–4280.
   PubMed Web of Science ®Google Scholar
• Boggild AK, Esposito DH, Kozarsky PE, Ansdell V, Beeching NJ, Campion D, Castelli F, Caumes E, Chappuis F, Cramer JP, et al. 2015. GeoSentinel Surveillance Network. Differential diagnosis of illness in travelers arriving from Sierra Leone, Liberia, or Guinea: a cross-sectional study from the GeoSentinel Surveillance Network. Ann Intern Med. 162:757–764.
   PubMed Web of Science ®Google Scholar
• Boisen ML, Oottamasathien D, Jones AB, Millett MM, Nelson DS, Bornholdt ZA, Fusco ML, Abelson DM, Oda S, Hartnett JN, et al. 2015. Development of prototype Filovirus recombinant antigen immunoassays. J Infect Dis. 212:S359–S367.
   PubMed Web of Science ®Google Scholar
• Borisevich IV, Mikhalov VV, Potryvaeva NV, MalinkinIu N, Kirillov AP, Krasnianski VP, Markov VI, Makhla AA, Lebedinskaia EV. 1996. Development of the immunoenzyme test-system for detection of Ebola virus antigen. Vopr Virusol. 41:232–234.
   PubMed Web of Science ®Google Scholar
• Bowen ET, Lloyd G, Harris WJ, Platt GS, Baskerville A, Vella EE. 1977. Viral haemorrhagic fever in southern Sudan and northern Zaire. Preliminary studies on the aetiological agent. Lancet. 1:571–573.
   PubMed Web of Science ®Google Scholar
• Brainard J, Pond K, Hooper L, Edmunds K, Hunter P. 2016. Presence and persistence of Ebola or Marburg virus in patients and survivors: a rapid systematic review. PLoS Negl Trop Dis. 10:e0004475.
   PubMed Web of Science ®Google Scholar
• Brauburger K, Boehmann Y, Tsuda Y, Hoenen T, Olejnik J, Schümann M, Ebihara H, Mühlberger E. 2014. Analysis of the highly diverse gene borders in Ebola virus reveals a distinct mechanism of transcriptional regulation. J Virol. 88:12558–12571.
   PubMed Web of Science ®Google Scholar
• Broadhurst MJ, Kelly JD, Miller A, Semper A, Bailey D, Groppelli E, Simpson A, Brooks T, Hula S, Nyoni W, et al. 2015. ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study. Lancet. 386:867–874.
   PubMed Web of Science ®Google Scholar
• Brown CM, Aranas AE, Benenson GA, Brunette G, Cetron M, Chen T, Cohen NJ, Diaz P, Haber Y, Hale CR, et al. 2014. Airport exit and entry screening for Ebola—August-November 10, 2014. MMWR Morb Mortal Wkly Rep. 63:1163–1167.
   PubMed Web of Science ®Google Scholar
• Bukreyev AA, Chandran K, Dolnik O, Dye JM, Ebihara H, Leroy EM, Mühlberger E, Netesov SV, Patterson JL, Paweska JT, et al. 2014. Discussions and decisions of the 2012–2014 International Committee on Taxonomy of Viruses (ICTV) Filoviridae Study Group, January 2012–June 2013. Arch Virol. 159:821–830.
   PubMed Web of Science ®Google Scholar
• Butler D. 2014. Ebola experts seek to expand testing. Nature. 516:154–155.
   PubMed Web of Science ®Google Scholar
• CDC. 1990a. Epidemiologic notes and reports ppdate: filovirus infection in animal handlers. MMWR Morb Mortal Wkly Rep. 39:221.
   PubMedGoogle Scholar
• CDC. 1990b. Update: filovirus infections among persons with occupational exposure to nonhuman primates. MMWR Morb Mortal Wkly Rep. 39:266—267, 273.
   Google Scholar
• CDC. 2015. Ebola outbreak in West Africa – case counts. [updated 2015 Apr 13]. Available from: http://www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/case-counts.html.
   Google Scholar
• CDC. 2015. Etymologia. Ebola. Emerg Infect Dis. 21:1905.
   PubMedGoogle Scholar
• CDC. 2015. Sierra Leone trial to introduce a vaccine against Ebola (STRIVE). Newsroom. Available from: http://www.cdc.media/releases/2015/o0414-ebola-vaccine.html
   Google Scholar
• Caballero IS, Honko AN, Gire SK, Winnicki SM, Melé M, Gerhardinger C, Lin AE, Rinn JL, Sabeti PC, Hensley LE, Connor JH. 2016. In vivo Ebola virus infection leads to a strong innate response in circulating immune cells. BMC Genomics. 17:707.
   PubMed Web of Science ®Google Scholar
• Cai H, Parks JW, Wall TA, Stott MA, Stambaugh A, Alfson K, Griffiths A, Mathies RA, Carrion R, Patterson JL, et al. 2015. Optofluidic analysis system for amplification-free, direct detection of Ebola infection. Sci Rep. 5:14494.
   PubMed Web of Science ®Google Scholar
• Calain P, Roux L, Kolakofsky D. 2016. Defective interfering genomes and Ebola virus persistence. Lancet. 388:659–660.
   PubMed Web of Science ®Google Scholar
• Calza L, Trapani F, Bartoletti M, Manfredi R, Colangeli V, Borderi M, Grossi G, Motta R, Viale P. 2012. Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor α in HIV-infected patients treated with ritonavir- boosted protease inhibitors. HIV Clin Trials. 13:153–161.
   PubMed Web of Science ®Google Scholar
• Carette JE, Raaben M, Wong AC, Herbert AS, Obernosterer G, Mulherkar N, Kuehne AI, Kranzusch PJ, Griffin AM, Ruthel G, et al. 2011. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature. 477:340–343.
   PubMed Web of Science ®Google Scholar
• Carney TJ, Weber DJ. 2015. Public health intelligence: learning from the Ebola crisis. Am J Public Health. 105:1740–1744.
   PubMed Web of Science ®Google Scholar
• Carra JH, Martins KA, Schokman RD, Robinson CG, Steffens JT, Bavari S. 2015. A thermostable, chromatographically purified Ebola nano-VLP vaccine. J Transl Med. 13:228.
   PubMed Web of Science ®Google Scholar
• Casillas AM, Nyamathi AM, Sosa A, Wilder CL, Sands H. 2003. A current review of Ebola virus: pathogenesis, clinical presentation, and diagnostic assessment. Biol Res Nurs. 4:268–275.
   PubMedGoogle Scholar
• Cazares LH, Ward MD, Brueggemann EE, Kenny T, Demond P, Mahone CR, Martins KAO, Nuss JE, Glaros T, Bavari S. 2016. Development of a liquid chromatography high resolution mass spectrometry method for the quantitation of viral envelope glycoprotein in Ebola virus-like particle vaccine preparations. Clin Proteomics. 13:18.
   PubMed Web of Science ®Google Scholar
• Cenciarelli O, Pietropaoli S, Malizia A, Carestia M, D'Amico F, Sassolini A, Di Giovanni D, Rea S, Gabbarini V, Tamburrini A, et al. 2015. Ebola virus disease 2013-2014 outbreak in West Africa: an analysis of the epidemic spread and response. Int J Microbiol. 2015:769121.
   PubMedGoogle Scholar
• Centers for Disease Control (CDC). 1989. Ebola virus infection in imported primates–Virginia, 1989. MMWR Morb Mortal Wkly Rep. 38:831–832, 837–838.
   Google Scholar
• Chabra S. 2015. International Classification of Diseases, 10th Revision, coding for prematurity: need for standardized nomenclature. Health Care Manag (Frederick). 34:123–127.
   PubMed Web of Science ®Google Scholar
• Chancellor JR, Padmanabhan SP, Greenough TC, Sacra R, Ellison III RT, Madoff LC, Droms RJ, Hinkle DM, Asdourian GK, Finberg RW, et al. 2016. Uveitis and systemic inflammatory markers in convalescent phase of Ebola virus disease. Emerg Infect Dis. 22:295–297.
   PubMed Web of Science ®Google Scholar
• Chappell KJ, Watterson. 2017. Fighting Ebola: a window for vaccine re-evaluation? PLoS Pathog. 13:e1006037. doi: 10.1371/journal.ppat.1006037.
   PubMed Web of Science ®Google Scholar
• Check HE. 2016. Ebola virus lingers longer than scientists thought. Nature. 537:291–292.
   PubMedGoogle Scholar
• Chen Z, Liang H, Chen X, Ke Y, Zhou Z, Yang M, Zen K, Yang R, Liu C, Zhang CY. 2016. An Ebola virus-encoded microRNA-like fragment serves as a biomarker for early diagnosis of Ebola virus disease. Cell Res. 26:380–383.
   PubMed Web of Science ®Google Scholar
• Cheng F, Murray JL, Zhao J, Sheng J, Zhao Z, Rubin DH. 2016. Systems biology-based investigation of cellular antiviral drug targets identified by gene-trap insertional mutagenesis. PLoS Comput Biol. 12:e1005074.
   PubMed Web of Science ®Google Scholar
• Cherpillod P, Schibler M, Vieille G, Cordey S, Mamin A, Vetter P, Kaiser L. 2016. Ebola virus disease diagnosis by real-time RT-PCR: a comparative study of 11 different procedures. J ClinVirol. 77:9–14.
   Google Scholar
• Chertow DS, Kleine C, Edwards JK, Scaini R, Giuliani R, Sprecher A. 2014. Ebola virus disease in West Africa – clinical manifestations and management. N Engl J Med. 371:2054–2057.
   PubMed Web of Science ®Google Scholar
• Chertow DS, Nath A, Suffredini AF, Danner RL, Reich DS, Bishop RJ, Childs RW, Arai AE, Palmore TN, Lane HC, et al. 2016. Severe meningoencephalitis in a case of Ebola virus disease: a case report. Ann Intern Med. 165:301–304.
   PubMed Web of Science ®Google Scholar
• Chiramel AI, Banadyga L, Dougherty JD, Falzarano D, Martellaro C, Brees D, Taylor RT, Ebihara H, Best SM. 2016. Alisporivir has limited antiviral effects against Ebola virus strains Makona and Mayinga. J Infect Dis. 214(S3):S355–S359.
   Web of Science ®Google Scholar
• Choi JH, Croyle MA. 2013. Emerging targets and novel approaches to Ebola virus prophylaxis and treatment. Bio Drugs. 27(6). doi:10.1007/2Fs40259-013-0046-1.
   Google Scholar
• Choi WY, Hong KJ, Hong JE, Lee WJ. 2015. Progress of vaccine and drug development for Ebola preparedness. Clin Exp Vaccine Res. 4:11–16.
   PubMed Web of Science ®Google Scholar
• Chretien JP, Riley S, George DB. 2015. Mathematical modeling of the West Africa Ebola epidemic. ELife. 4:e09186.
   PubMed Web of Science ®Google Scholar
• Christaki E. 2015. New technologies in predicting, preventing and controlling emerging infectious diseases. Virulence. 6:558–565.
   PubMed Web of Science ®Google Scholar
• Chughtai AA, Barnes M, Macintyre CR. 2016. Persistence of Ebola virus in various body fluids during convalescence: evidence and implications for disease transmission and control. Epidemiol Infect. 25:1–9.
   Google Scholar
• Coen A, Henk M. How the virus came into this world. Die Zeit. 2015. Available from: http://www.zeit.de/feature/ebola-afrika-virus.
   Google Scholar
• Cohen J. 2014. Infectious disease. Ebola vaccines racing forward at record pace. Science. 345:1228–1229.
   PubMed Web of Science ®Google Scholar
• Corti D, Misasi J, Mulangu S, Stanley DA, Kanekiyo M, Wollen S, Ploquin A, Doria-Rose NA, Staupe RP, Bailey M, et al. 2016. Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody. Science. 351:1339–1342.
   PubMed Web of Science ®Google Scholar
• Cross RW, Boisen ML, Millett MM, Nelson DS, Oottamasathien D, Hartnett JN, Jones AB, Goba A, Momoh M, Fullah M, Bornholdt ZA. 2016. Analytical validation of the ReEBOV antigen rapid test for point-of-care diagnosis of Ebola virus infection. J Infect Dis. 214(S3):S210–S217.
   PubMed Web of Science ®Google Scholar
• Curran KG, Gibson JJ, Marke D, Caulker V, Bomeh J, Redd JT, Bunga S, Brunkard J, Kilmarx PH. 2016. Cluster of Ebola virus disease linked to a single funeral – Moyamba District, Sierra Leone, 2014. MMWR Morb Mortal Wkly Rep. 65:202–205.
   PubMed Web of Science ®Google Scholar
• Dedkov VG, Magassouba NF, Safonova MV, Deviatkin AA, Dolgova AS, Pyankov OV, Sergeev AA, Utkin DV, Odinokov GN, Safronov VA, et al. 2016. Development and evaluation of a real-time RT-PCR assay for the detection of Ebola virus (Zaire) during an Ebola outbreak in Guinea in 2014-2015. J Virol Methods. 228:26–30.
   PubMed Web of Science ®Google Scholar
• Deen GF, Knust B, Broutet N, Sesay FR, Formenty P, Ross C, Thorson AE, Massaquoi TA, Marrinan JE, Ervin E, et al. 2015. Ebola RNA persistence in semen of Ebola virus disease survivors – preliminary report. N Engl J Med. 52:714–721.
   Google Scholar
• Delany I, Rappuoli R, De Gregorio E. 2014. Vaccines for the 21st century. EMBO Mol Med 6:708–720.
   PubMed Web of Science ®Google Scholar
• Dhama K, Chakraborty S, Mahima, Wani MY, Verma AK, Deb R, Tiwari R, Kapoor S. 2013. Novel and emerging therapies safeguarding health of humans and their companion animals: a review. Pak J Biol Sci. 16:101–111.
   PubMedGoogle Scholar
• Dhama K, Karthik K, Chakraborty S, Tiwari R, Kapoor S, Kumar A, Thomas P. 2014. Loop-mediated isothermal amplification of DNA (LAMP) – a new diagnostic tool lights the world of diagnosis of animal and human pathogens: a review. Pak J Biol Sci. 17:151–166.
   PubMedGoogle Scholar
• Dhama K, Malik YS, Malik SV, Singh RK. 2015. Ebola from emergence to epidemic: the virus and the disease, global preparedness and perspectives. J Infect Dev Ctries. 9:441–455.
   PubMed Web of Science ®Google Scholar
• Dhama K, Saminathan M, Jacob SS, Singh M, Karthik K, Amarpal, Tiwari R, Sunkara LT, Malik YS, Singh RK. 2015. Effect of immunomodulation and immunomodulatory agents on health with some bioactive principles, modes of action and potent biomedical applications. Int J Pharmacol. 11:253–290.
   Web of Science ®Google Scholar
• Dhama K, Tiwari R, Chakraborty S, Kumar A, Karikalan M, Singh R, Rai RB. 2013. Global warming and emerging infectious diseases of animals and humans: current scenario, challenges, solutions and future perspectives – a review. Int J Curr Res. 5:1942–1958.
   Google Scholar
• Dhama K, Wani MY, Deb R, Karthik K, Tiwari R, Barathidasan R, Kumar A, Mahima, Verma AK, Singh SD. 2013. Plant based oral vaccines for human and animal pathogens – a new era of prophylaxis: current and future prospective. J Exp Biol Agri Sci. 1:1–12.
   Google Scholar
• Dhillon RS, Srikrishna D, Garry RF, Chowell G. 2015. Ebola control: rapid diagnostic testing. Lancet Infect Dis. 15:147–48.
   PubMed Web of Science ®Google Scholar
• Dolzhikova IV, Zubkova OV, Tukhvatulin AI, Dzharullaeva AS, Tukhvatulina NM, Shcheblyakov DV, Shmarov MM, Tokarskaya EA, Simakova YV, Egorova DA, et al. 2017. Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: an open phase I/II trial in healthy adults in Russia. Hum Vaccin Immunother. 2:1–8. doi:10.1080/21645515.2016.1238535.
   Web of Science ®Google Scholar
• Dong S, Yang P, Li G, Liu B, Wang W, Liu X, Xia B, Yang C, Lou Z, Guo Y, Rao Z. 2015. Insight into the Ebola virus nucleocapsid assembly mechanism: crystal structure of Ebola virus nucleoprotein core domain at 1.8 Å resolution. Protein Cell. 6:351–362.
   PubMed Web of Science ®Google Scholar
• Dowell SF, Mukunu R, Ksiazek TG, Khan AS, Rollin PE, Peters CJ. 1999. Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis. 179:S87–91.
   PubMed Web of Science ®Google Scholar
• Drosten C, Gottig S, Schilling S, Asper M, Panning M, Schmitz H, Gunther S. 2002. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J Clin Microbiol. 40:2323–2330.
   PubMed Web of Science ®Google Scholar
• Duan D, Fan K, Zhang D, Tan S, Liang M, Liu Y, Zhang J, Zhang P, Liu W, Qiu X, et al. 2015. Nanozyme-strip for rapid local diagnosis of Ebola. Biosens Bioelectron. 74:134–141.
   PubMed Web of Science ®Google Scholar
• Dunning J, Kennedy SB, Antierens A, Whitehead J, Ciglenecki I, Carson G, Kanapathipillai R, Castle L, Howell-Jones R, Pardinaz-Solis R, et al. 2016. Experimental treatment of Ebola virus disease with brincidofovir. PloS One. 11:e0162199.
   PubMed Web of Science ®Google Scholar
• Dye JM, Herbert AS, Kuehne AI, Barth JF, Muhammad MA, Zak SE, Ortiz RA, Prugar LI, Pratt WD. (2012). Postexposure antibody prophylaxis pro-tects nonhuman primates from filovirus disease. Proc Natl Acad Sci. 109:5034–5039.
   PubMed Web of Science ®Google Scholar
• El Sayed SM, Abdelrahman AA, Ozbak HA, Hemeg HA, Kheyami AM, Rezk N, El-Ghoul MB, Nabo MM, Fathy YM. 2016. Updates in diagnosis and management of Ebola hemorrhagic fever. J Res Med Sci. 18:84.
   Web of Science ®Google Scholar
• Elstona JWT, Cartwright C, Ndumbi P, Wright J. 2017. The health impact of the 2014–15 Ebola outbreak. Public Health 143:60–70.
   PubMed Web of Science ®Google Scholar
• Emond RT, Evans B, Bowen ET, Lloyd G. 1977. A case of Ebola virus infection. BMJ. 2:541–544.
   PubMed Web of Science ®Google Scholar
• Erhabor O, Adias TC. 2011. From whole blood to component therapy: the economic, supply/demand need for implementation of component therapy in sub-Saharan Africa. Transfus Clin Biol. 18:516–526.
   PubMed Web of Science ®Google Scholar
• Fallah MP, Skrip LA, Dahn BT, Nyenswah TG, Flumo H, Glayweon M, Lorseh TL, Kaler SG, Higgs ES, Galvani AP. 2016. Pregnancy outcomes in Liberian women who conceived after recovery from Ebola virus disease. Lancet Glob Health. 4:e678–e679.
   PubMed Web of Science ®Google Scholar
• Falzarano D, Geisbert TW, Feldmann H. 2011. Progress in filovirus vaccine development: evaluating the potential for clinical use. Expert Rev Vaccines. 10:63–77.
   PubMed Web of Science ®Google Scholar
• Fauci AS. 2014. Ebola-underscoring the global disparities in health care resources. New Eng J Med. 371:1084–1086.
   PubMed Web of Science ®Google Scholar
• Faye O, Faye O, Soropogui B, Patel P, El Wahed AA, Loucoubar C, Fall G, Kiory D, Magassouba N, Keita S, et al. 2015. Development and deployment of a rapid recombinase polymerase amplification Ebola virus detection assay in Guinea in 2015. Euro Surveill. 20. doi: 10.2807/1560-7917.ES.2015.20.44.30053. Erratum in: Euro Surveill. 2016;21(4). doi:10.2807/1560-7917.ES.2016.21.4.30121.
   PubMedGoogle Scholar
• Feldmann FL, Feldmann H. 2014. Ebola: facing a new transboundary animal disease ? Dev Biol (Basel). 135:201–209.
   Google Scholar
• Feldmann H, Bugany H, Mahner F, Klenk HD, Drenckhahn D, Schnittler HJ. 1996. Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. J Virol. 70:2208–2214.
   PubMed Web of Science ®Google Scholar
• Feldmann H, Geisbert TW. 2011. Ebola haemorrhagic fever. Lancet. 377:849–862.
   PubMed Web of Science ®Google Scholar
• Felsenstein J. 1985. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39:783–791.
   PubMed Web of Science ®Google Scholar
• Fischer RJ, Judson S, Miazgowicz K, Bushmaker T, Munster VJ. 2016. Ebola virus persistence in semen ex vivo. Emerg Infect Dis. 22:289–291.
   PubMed Web of Science ®Google Scholar
• Flint M, Goodman CH, Bearden S, Blau DM, Amman BR, Basile AJ, Belser JA, Bergeron É, Bowen MD, Brault AC, et al. 2015. Ebola virus diagnostics: the US Centers for Disease Control and Prevention Laboratory in Sierra Leone, August 2014 to March 2015. J Infect Dis. 212:S350–S358.
   PubMed Web of Science ®Google Scholar
• Florescu DF, Kalil AC, Hewlett AL, Schuh AJ, Stroher U, Uyeki TM, Smith PW. 2015. Administration of brincidofovir and convalescent plasma in a patient with Ebola virus disease. Clin Infect Dis. 61:969–973.
   PubMed Web of Science ®Google Scholar
• Florescu DF, Keck MA. 2014. Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses. Expert Rev Anti Infect Ther. 12:1171–1178.
   PubMed Web of Science ®Google Scholar
• Folayan MO, Yakubu A, Haire B, Peterson K. 2016. Ebola vaccine development plan: ethics, concerns and proposed measures. BMC Medical Ethics. 17:10. doi:10.1186/s12910-016-0094-4.
   PubMed Web of Science ®Google Scholar
• Formenty P, Boesch C, Wyers M, Steiner C, Donati F, Dind F, Walker F, Le Guenno B. 1999. Ebola virus outbreak among wild chimpanzees living in a rain forest of Côte d'Ivoire. J Infect Dis. 179:S120–126.
   PubMed Web of Science ®Google Scholar
• Formenty P, Hatz C, Le Guenno B, Stoll A, Rogenmoser P, Widmer A. 1999. Human infection due to Ebola virus, subtype Côte d'Ivoire: clinical and biologic presentation. J Infect Dis. 179:S48–53.
   PubMed Web of Science ®Google Scholar
• Formenty P, Leroy EM, Epelboin A, Libama F, Lenzi M, Sudeck H, Yaba P, Allarangar Y, Boumandouki P, Nkounkou VB, et al. 2006. Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin Infect Dis. 42:1521–1526.
   PubMed Web of Science ®Google Scholar
• Formenty P, Libama F, Epelboin A, Allarangar Y, Leroy E, Moudzeo H, Tarangonia P, Molamou A, Lenzi M, Ait-Ikhlef K, et al. 2003. Outbreak of Ebola hemorrhagic fever in the Republic of the Congo, 2003: a new strategy? Med Trop (Mars). 63:291–295.
   PubMedGoogle Scholar
• Francesconi P, Yoti Z, Declich S, Onek PA, Fabiani M, Olango J, Andraghetti R, Rollin PE, Opira C, Greco D, Salmaso S. 2003. Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda. Emerg Infect Dis. 9:1430–1437.
   PubMed Web of Science ®Google Scholar
• Friedrich MJ. 2016. Clinical sequelae of Ebola. JAMA. 315:647.
   Web of Science ®Google Scholar
• Fähnrich C, Denecke K, Adeoye OO, Benzler J, Claus H, Kirchner G, Mall S, Richter R, Schapranow MP, Schwarz N, et al. 2015. Surveillance and outbreak response management system (SORMAS) to support the control of the Ebola virus disease outbreak in West Africa. Euro Surveill. 20:21071.
   PubMedGoogle Scholar
• Gallaher WR, Garry RF. 2015. Modeling of the Ebola virus delta peptide reveals a potential lytic sequence motif. Viruses. 7:285–305.
   PubMed Web of Science ®Google Scholar
• Gao J, Yin L. 2014. Drug development for controlling Ebola epidemic – a race against time. Drug Discov Ther. 8:229–231.
   PubMedGoogle Scholar
• Gatherer D. 2014. The 2014 Ebola virus disease outbreak in West Africa. J Gen Virol. 95:1619–1624.
   PubMed Web of Science ®Google Scholar
• Gehring G, Rohrmann K, Atenchong N, Mittler E, Becker S, Dahlmann F, Pöhlmann S, Vondran FW, David S, Manns MP, et al. 2014. The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry. J Antimicrob Chemother. 69:2123–2131.
   PubMed Web of Science ®Google Scholar
• Geisbert T, Hensley L, Larsen T, Young H, Reed D, Geisbert J, Scott D, Kagan E, Jahrling P, Davis K. 2003a. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques. Am J Pathol. 163:2347–2370.
   PubMed Web of Science ®Google Scholar
• Geisbert TW, Geisbert JB, Leung A, Daddario-DiCaprio KM, Hensley LE, Grolla A, Feldmann H. 2009. Single-injection vaccine protects nonhuman primates against infection with Marburg virus and three species of Ebola virus. J Virol. 83:7296–7304.
   PubMed Web of Science ®Google Scholar
• Geisbert TW, Hensley LE, Jahrling PB, Larsen T, Geisbert JB, Paragas JJ, Young HA, Fredeking TM, Rote WE, Vlasuk GP. 2003b. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/ tissue factor: a study in rhesus monkeys. Lancet. 13:1953–1958.
   Web of Science ®Google Scholar
• Geisbert TW, Jahrling PB. 2003. Towards a vaccine against Ebola virus. Expert Rev Vaccines. 2:777–789.
   PubMedGoogle Scholar
• Geisbert TW, Lee AC, Robbins M, Geisbert JB, Honko AN, Sood V, Johnson JC, de Jong S, Tavakoli I, Judge A, et al. 2010. Post exposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study. Lancet. 375:1896–1905.
   PubMed Web of Science ®Google Scholar
• Georges-Courbot MC, Sanchez A, Lu CY, Baize S, Leroy E, Lansout-Soukate J, Tévi-Bénissan C, Georges AJ, Trappier SG, Zaki SR, et al. 1997. Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon. Emerg Infect Dis. 3:59–62.
   PubMed Web of Science ®Google Scholar
• Georges AJ, Leroy EM, Renaut AA, Benissan CT, Nabias RJ, Ngoc MT, Obiang PI, Lepage JP, Bertherat EJ, Bénoni DD, et al. 1999. Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: epidemiologic and health control issues. J Infect Dis. 179:S65–S75.
   PubMed Web of Science ®Google Scholar
• Ghani AC, Burgess DH, Reynolds A, Rousseau C. 2015. Expanding the role of diagnostic and prognostic tools for infectious diseases in resource-poor settings. Nature. 528:S50–S52.
   PubMed Web of Science ®Google Scholar
• Gibb TR, Norwood DA Jr, Woollen N, Henchal EA. 2001. Development and evaluation of a fluorogenic 5' nuclease assay to detect and differentiate between Ebola virus subtypes Zaire and Sudan. J Clin Microbiol. 39:4125–4130.
   PubMed Web of Science ®Google Scholar
• Gilbert GL. 2015. Laboratory testing in management of patients with suspected Ebolavirus disease: infection control and safety. Pathology. 47:400–402.
   PubMed Web of Science ®Google Scholar
• Gire SK, Goba A, Andersen KG, Sealfon RSG, Park DJ, Kanneh L, Jalloh S, Momoh M, Fullah M, Dudas G, et al. 2014. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science. 345:1369–1372.
   PubMed Web of Science ®Google Scholar
• Gonzalez JP, Pourrut X, Leroy E. 2007. Ebolavirus and other filoviruses.Curr Top Microbiol Immunol. 315:363–387.
   Google Scholar
• Grard G, Biek R, Tamfum J-JM, Fair J, Wolfe N, Formenty P, Paweska J, Leroy E. 2011. Emergence of divergent Zaire ebola virus strains in Democratic Republic of the Congo in 2007 and 2008. J Infect Dis. 204:S776–S784.
   PubMed Web of Science ®Google Scholar
• Guimard Y, Bwaka MA, Colebunders R, Calain P, Massamba M, De Roo A, Mupapa KD, Kibadi K, Kuvula KJ, Ndaberey DE, et al. 1999. Organization of patient care during the Ebola hemorrhagic fever epidemic in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis. 179: S268–S273.
   PubMed Web of Science ®Google Scholar
• Gulland A. 2014. First Ebola treatment is approved by WHO. British Med J. 349:g5539.
   PubMed Web of Science ®Google Scholar
• Haque A, Hober D, Blondiaux J. 2015. Addressing therapeutic options for Ebola virus infection in current and future outbreaks. Antimicrob Agents Chemother. 59:5892–5902.
   PubMed Web of Science ®Google Scholar
• Hartman AL, Towner JS, Nichol ST. 2010. Ebola and Marburg hemorrhagic fever. Clin Lab Med. 30:161–177.
   PubMed Web of Science ®Google Scholar
• Hartmann RK, Grünweller A, Strecker T. 2017. Persistence of Ebola virus in the semen of male survivors. J Public Health Emerg 1:23.
   Google Scholar
• Harty RN, Brown ME, Wang G, Huibregtse J, Hayes FP. 2000. A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding. Proc Natl Acad Sci USA. 97:13871–13876.
   PubMed Web of Science ®Google Scholar
• Hassanin A, Nesi N, Marin J, Kadjo B, Pourrut X, Leroy É, Gembu GC, Musaba Akawa P, Ngoagouni C, Nakouné E, et al. 2016. Comparative phylogeography of African fruit bats (Chiroptera, Pteropodidae) provide new insights into the outbreak of Ebola virus disease in West Africa, 2014-2016. C R Biol. 339:517–528.
   PubMed Web of Science ®Google Scholar
• Hayes CG, Burans JP, Ksiazek TG, Del Rosario RA, Miranda ME, Manaloto CR, Barrientos AB, Robles CG, Dayrit MM, Peters CJ. 1992. Outbreak of fatal illness among captive macaques in the Philippines caused by an Ebola-related filovirus. Am J Trop Med Hyg. 46:664–671.
   PubMed Web of Science ®Google Scholar
• Heald AE, Iversen PL, Saoud JB, Sazani P, Charleston JS, Axtelle T, Wong M, Smith WB, Vutikullird A, Kaye E. 2014. Safety and pharmacokinetic profiles of phosphorodiamidate morpholino oligomers with activity against Ebola virus and Marburg virus: results of two single ascending- dose studies. Antimicrob Agents Chemother. 58:6639–6647.
   PubMed Web of Science ®Google Scholar
• Hebert EH, Bah MO, Etard JF, Sow MS, Resnikoff S, Fardeau C, Tourea A, Ouendeno AN, Sagno IC, March L, et al. 2017. Ocular complications in survivors of the Ebola outbreak in Guinea. AmJ Ophthalmol. 175:114–121.
   PubMed Web of Science ®Google Scholar
• Heeney JL. 2015. Ebola: hidden reservoirs. Nature. 527:453–455.
   PubMed Web of Science ®Google Scholar
• Henß L, Beck S, Weidner T, Biedenkopf N, Sliva K, Weber C, Becker S, Schnierle BS. 2016. Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry. Virology J. 13:149.
   PubMed Web of Science ®Google Scholar
• Heymann DL, Weisfeld JS, Webb PA, Johnson KM, Cairns T, Berquist H. 1980. Ebola hemorrhagic fever: Tandala, Zaire, 1977-1978. J Infect Dis. 142:372–376.
   PubMed Web of Science ®Google Scholar
• Ho WE, Peh HY, Chan TK, Wong WS. 2014. Artemisinins: pharmacological actions beyond anti-malarial. Pharmacol Ther. 142:126–139.
   PubMed Web of Science ®Google Scholar
• Hoenen T, Groseth A, Falzarano D, Feldmann H. 2006. Ebola virus: unravelling pathogenesis to combat a deadly disease. Trends Mol Med. 12:206–215.
   PubMed Web of Science ®Google Scholar
• Hoenen T, Groseth A, Feldmann H. 2012. Current Ebola vaccines. Expert Opin Biol Ther. 12:859–872.
   PubMed Web of Science ®Google Scholar
• Hossain L, Kam D, Kong F, Wigand RT, Bossomaier T. 2016. Social media in Ebola outbreak. Epidemiol Infect. 4:1–8.
   Google Scholar
• Houssin T, Cramer J, Grojsman R, Bellahsene L, Colas G, Moulet H, Minnella W, Pannetier C, Leberre M, Plecis A, Chen Y. 2016. Ultrafast, sensitive and large-volume on-chip real-time PCR for the molecular diagnosis of bacterial and viral infections. Lab Chip. 16:1401–1411. Available from: http://www.nature.com/scitable/blog/viruses101/the_scientist_who_discovered_ebola; http://www.theaustralian.com.au/news/world/the-times/russians-died-in-ebola-weapons-lab/news-story/e426b0bd0064da5fe8c78e4d485c162c; http://www.who.int/csr/disease/ebola/ebola-6-months/guinea/en/; http://www.who.int/wer/2003/en/wer7826.pdf; https://www.washingtonpost.com/national/health-science/2014/10/23/ce409716-5945-11e4-b812-38518ae74c67_story.html
   PubMed Web of Science ®Google Scholar
• Huang Y, Wei H, Wang Y, Shi Z, Raoul H, Yuan Z. 2012. Rapid detection of filoviruses by real-time TaqMan polymerase chain reaction assays. Virol Sin. 27:273–277.
   PubMedGoogle Scholar
• Huang Y, Zhu Y, Yang M, Zhang Z, Song D, Yuan Z. 2014. Nucleoprotein-based indirect enzyme-linked immunosorbent assay (indirect ELISA) for detecting antibodies specific to Ebola virus and Marburg virus. Virol Sin. 29:372–380.
   PubMedGoogle Scholar
• Iqbal HM, Villalba A, Khandia R, Munjal A, Dhama K. 2016. Recent trends in nanotechnology-based drugs and formulations for targeted therapeutic delivery. Recent Pat Inflamm Allergy Drug Discov. 10(2):86–93.
   Google Scholar
• Iversen PL, Warren TK, Wells JB, Garza NL, Mourich DV, Welch LS, Panchal RG, Bavari S. 2012. Discovery and early development of AVI-7537 and AVI-7288 for the treatment of Ebola virus and Marburg virus infections. Viruses. 4:2806–2830.
   PubMed Web of Science ®Google Scholar
• Jaax N, Jahrling P, Geisbert T, Geisbert J, Steele K, McKee K, Nagley D, Johnson E, Jaax G, Peters C. 1995. Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory. Lancet. 346:1669–1671.
   PubMed Web of Science ®Google Scholar
• Jaax NK, Davis KJ, Geisbert TJ, Vogel P, Jaax GP, Topper M, Jahrling PB. 1996. Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch Pathol Lab Med. 120:140–155.
   PubMed Web of Science ®Google Scholar
• Jacobsen KH, Aguirre AA, Bailey CL, Baranova AV, Crooks AT, Croitoru A, Delamater PL, Gupta J, Kehn-Hall K, Narayanan A, et al. 2016. Lessons from the Ebola outbreak: action items for emerging infectious disease preparedness and response. Ecohealth. 13:200–212.
   PubMed Web of Science ®Google Scholar
• Jahrling PB, Geisbert TW, Dalgard DW, Johnson ED, Ksiazek TG, Hall WC, Peters CJ. 1990. Preliminary report: isolation of Ebola virus from monkeys imported to USA. Lancet. 335:502–505.
   PubMed Web of Science ®Google Scholar
• Jahrling PB, Joan B. Geisbert JB, Swearengen JR, Larsen T, Thomas W, Geisbert TW. 2007. Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates. J Infect Dis. 196:S400–S403.
   PubMed Web of Science ®Google Scholar
• Jahromi MK, Mood BS. 2015. Ebola hemorrhagic fever. Int J Infect. 2:e22401.
   Google Scholar
• Japtok L, Kleuser B. 2009. The role of sphingosine-1-phosphate receptor modulators in the prevention of transplant rejection and autoimmune diseases. Curr Opin Invest Drugs. 10:1183–1194.
   PubMedGoogle Scholar
• Jasenosky LD, Neumann G, Lukashevich I, Kawaoka Y. 2001. Ebola virus VP40-induced particle formation and association with the lipid bilayer. J Virol. 75:5205–5214.
   PubMed Web of Science ®Google Scholar
• Jayme SI, Field HE, de Jong C, Olival KJ, Marsh G, Tagtag AM, Hughes T, Bucad AC, Barr J, Azul RR, et al. 2015. Molecular evidence of Ebola Reston virus infection in Philippine bats. Virol J. 12:107. doi:10.1186/s12985-015-0331-3.
   PubMed Web of Science ®Google Scholar
• Jensen van Vuren P, Grobbelaar A, Storm N, Conteh O, Konneh K, Kamara A, Sanne I, Paweska JT. 2016. Comparative evaluation of the diagnostic performance of the Prototype Cepheid GeneXpert Ebola Assay. J Clin Microbiol. 54:359–367.
   PubMed Web of Science ®Google Scholar
• Jia K, Mohamed K. 2015. Evaluating the use of cell phone messaging for community Ebola syndromic surveillance in high risked settings in Southern Sierra Leone. Afr Health Sci. 15:797–802.
   PubMed Web of Science ®Google Scholar
• Johansen LM, Brannan JM, Delos SE, Shoemaker CJ, Stossel A, Lear C, Hoffstrom BG, Dewald LE, Schornberg KL, Scully C, et al. 2013. FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection. Sci Transl Med. 5:190ra79.
   PubMed Web of Science ®Google Scholar
• Johnson E, Jaax N, White J, Jahrling P. 1995. Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus. Int J Exp Pathol. 76:227–236.
   PubMed Web of Science ®Google Scholar
• Johnson JC, Martinez O, Honko AN, Hensley LE, Olinger GG, Basler CF. 2014. Pyridinyl imidazole inhibitors of p38 MAP kinase impair viral dendritic cells. Antiviral Res. 107:102–109.
   PubMed Web of Science ®Google Scholar
• Johnson KM, Lange JV, Webb PA, Murphy FA. 1977. Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire. Lancet. 1:569–571.
   PubMed Web of Science ®Google Scholar
• Johnson KM. 1978. Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ. 56:271–293.
   PubMed Web of Science ®Google Scholar
• Jones SM, Feldmann H, Ströher U, Geisbert JB, Fernando L, Grolla A, Klenk HD, Sullivan NJ, Volchkov VE, Fritz EA, et al. 2005. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med. 11:786–790.
   PubMed Web of Science ®Google Scholar
• Judson SD, Fischer R, Judson A, Munster VJ. 2016. Ecological contexts of index cases and spillover events of different Ebolaviruses. PLoS Pathog. 12:e1005780.
   PubMed Web of Science ®Google Scholar
• Jun SR, Leuze MR, Nookaew I, Uberbacher EC, Land M, Zhang Q, Wanchai V, Chai J, Nielsen M, Trolle T, et al. 2015. Ebolavirus comparative genomics. FEMS Microbiol Rev. 39:764–778.
   PubMed Web of Science ®Google Scholar
• Jääskeläinen AJ, Moilanen K, Aaltonen K, Putkuri N, Sironen T, Kallio-Kokko H, Vapalahti O. 2015. Development and evaluation of a real-time EBOV-L-RT-qPCR for detection of Zaire ebolavirus. J ClinVirol. 67:56–58.
   Google Scholar
• Kanduc D. 2016. Peptides for anti-Ebolavirus vaccines. Curr Drug Discov Technol. 13(4):225–231.
   PubMedGoogle Scholar
• Kangbai JB. 2016. Social network analysis and modeling of cellphone-based syndromic surveillance data for Ebola in Sierra Leone. Asian Pac J Trop Med. 9:851–855.
   PubMed Web of Science ®Google Scholar
• Khan AS, Tshioko FK, Heymann DL, Le Guenno B, Nabeth P, Kerstiëns B, Fleerackers Y, Kilmarx PH, Rodier GR, Nkuku O, et al. 1999. The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis. 179:S76–S86.
   PubMed Web of Science ®Google Scholar
• Kibadi K, Mupapa K, Kuvula K, Massamba M, Ndaberey D, Muyembe-Tamfum JJ, Bwaka MA, De Roo A, Colebunders R. 1999. Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the Congo. J Infect Dis. 179:S13–S14.
   PubMed Web of Science ®Google Scholar
• Kilgore PE, Grabenstein JD, Salim AM, Rybak M. 2015. Treatment of Ebola virus disease. Pharmacotherapy. 35:43–53.
   PubMed Web of Science ®Google Scholar
• Kobinger GP, Leung A, Neufeld J, Richardson JS, Falzarano D, Smith G, Tierney K, Patel A, Weingartl HM. 2011. Replication, pathogenicity, shedding, and transmission of Zaire ebolavirus in pigs. J Infect Dis. 204:200–208.
   PubMed Web of Science ®Google Scholar
• Konduru K, Shurtleff AC, Bradfute SB, Nakamura S, Bavari S, Kaplan G. 2016. Ebolavirus glycoprotein Fc fusion protein protects guinea pigs against lethal challenge. Plos One. 11:e0162446.
   PubMed Web of Science ®Google Scholar
• Kost GJ, Ferguson WJ, Hoe J, Truong AT, Banpavichit A, Kongpila S. 2015. The Ebola Spatial Care Path™: accelerating point-of-care diagnosis, decision making, and community resilience in outbreaks. Am J Disaster Med. 10:121–143.
   PubMedGoogle Scholar
• Krähling V, Becker D, Rohde C, Eickmann M, Eroğlu Y, Herwig A, Kerber R, Kowalski K, Vergara-Alert J, Becker S. 2016. European mobile laboratory consortium. Development of an antibody capture ELISA using inactivated Ebola Zaire Makona virus. Med Microbiol Immunol. 205:173–183.
   PubMed Web of Science ®Google Scholar
• Ksiazek TG, Rollin PE, Jahrling PB, Johnson E, Dalgard DW, Peters CJ. 1992. Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates. J Clin Microbiol. 30:947–950.
   PubMed Web of Science ®Google Scholar
• Ksiazek TG, Rollin PE, Williams AJ, Bressler DS, Martin ML, Swanepoel R, Burt FJ, Leman PA, Khan AS, Rowe AK, et al. 1999. Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis. 179:S177–S187.
   PubMed Web of Science ®Google Scholar
• Ksiazek TG, West CP, Rollin PE, Jahrling PB, Peters CJ. 1999. ELISA for the detection of antibodies to Ebola viruses. J Infect Dis. 179:S192–S198.
   PubMed Web of Science ®Google Scholar
• Kuehne A, Tiffany A, Lasry E, Janssens M, Besse C, Okonta C, Larbi K, Pah AC, Danis K, Porten K. 2016. Impact and lessons learned from mass drug administrations of malaria chemoprevention during the Ebola outbreak in Monrovia, Liberia, 2014. PloS One. 11:e0161311.
   PubMed Web of Science ®Google Scholar
• Kuhn JH, Andersen KG, Baize S, Bào Y, Bavari S, Berthet N, Blinkova O, Brister JR, Clawson AN, Fair J, et al. 2014. Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014. Viruses. 6:4760–4799.
   PubMed Web of Science ®Google Scholar
• Kuhn JH, Bao Y, Bavari S, Becker S, Bradfute S, Brister JR, Bukreyev AA, Caì Y, Chandran K, Davey RA, et al. 2013. Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae. Arch Virol. 158:1425–1432.
   PubMed Web of Science ®Google Scholar
• Kuhn JH, Becker S, Ebihara H, Geisbert TW, Johnson KM, Kawaoka Y, Lipkin WI, Negredo AI, Netesov SV, Nichol ST, et al. 2010. Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol. 155:2083–2103.
   PubMed Web of Science ®Google Scholar
• Kuhn JH, Bào Y, Bavari S, Becker S, Bradfute S, Brauburger K, Rodney Brister J, Bukreyev AA, Caì Y, Chandran K, et al. 2014. Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA. Arch Virol. 159:1229–1237.
   PubMed Web of Science ®Google Scholar
• Kurata T, Hondo R, Sato S, Oda A, Aoyama Y, McCormick JB. 1983. Detection of viral antigens in formalin-fixed specimens by enzyme treatment. Ann N Y Acad Sci. 420:192–207.
   PubMed Web of Science ®Google Scholar
• Kurosaki Y, Magassouba N, Oloniniyi OK, Cherif MS, Sakabe S, Takada A, Hirayama K, Yasuda J. 2016. Development and evaluation of reverse transcription-loop-mediated isothermal amplification (RT-LAMP) assay coupled with a portable device for rapid diagnosis of Ebola virus disease in Guinea. PLoS Negl Trop Dis. 10:e0004472.
   PubMed Web of Science ®Google Scholar
• Kurosaki Y, Takada A, Ebihara H, Grolla A, Kamoc N, Feldmann H, Kawaoka Y, Yasuda J. 2007. Rapid and simple detection of Ebola virus by reverse transcription-loop-mediated isothermal amplification. J Virol Methods. 141:78–83.
   PubMed Web of Science ®Google Scholar
• Lahm SA, Kombila M, Swanepoel R, Barnes RFW. 2007. Morbidity and mortality of wild animals in relation to outbreaks of Ebola haemorrhagic fever in Gabon, 1994-2003. Trans R Soc Trop Med Hyg. 101:64–78.
   PubMed Web of Science ®Google Scholar
• Lawrence P, Danet N, Reynard O, Volchkova V, Volchkov V. 2017. Human transmission of Ebola virus. Curr Opin Virol. 22:51–58.
   PubMed Web of Science ®Google Scholar
• Lazard AJ, Scheinfeld E, Bernhardt JM, Wilcox GB, Suran M. 2015. Detecting themes of public concern: a text mining analysis of the Centers for Disease Control and Prevention's Ebola live Twitter chat. Am J Infect Control. 43:1109–1111.
   PubMed Web of Science ®Google Scholar
• Le Guenno B, Formenty P, Formentry P, Wyers M, Gounon P, Walker F, Boesch C. 1995. Isolation and partial characterisation of a new strain of Ebola virus. Lancet. 345:1271–1274.
   PubMed Web of Science ®Google Scholar
• Ledgerwood JE, Costner P, Desai N, Holman L, Enama ME, Yamshchikov G, Mulangu S, Hu Z, Andrews CA, Sheets RA, et al. 2010. A replication defective recombinant AD5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults. Vaccine. 29:304–313.
   PubMed Web of Science ®Google Scholar
• Lee JE, Saphire EO. 2009. Ebolavirus glycoprotein structure and mechanism of entry. Future Virol. 4:621–635.
   PubMed Web of Science ®Google Scholar
• Leroy E, Epelboin A, Mondonge V, Pourrut X, Gonzalez JP, Muyembe-Tamfum JJ, Formenty P. 2009. Human Ebola outbreak resulting from direct exposure to fruit bats in Luebo, Democratic Republic of Congo, 2007. Vector Borne Zoonotic Dis. 9:723–728.
   PubMed Web of Science ®Google Scholar
• Leroy EM, Baize S, Lu CY, McCormick JB, Georges AJ, Georges-Courbot MC, Lansoud-Soukate J, Fisher-Hoch SP. 2000. Diagnosis of Ebola haemorrhagic fever by RT-PCR in an epidemic setting. J Med Virol. 60:463–467.
   PubMed Web of Science ®Google Scholar
• Leroy EM, Kumulungui B, Pourrut X, Rouquet P, Hassanin A, Yaba P, Délicat A, Paweska JT, Gonzalez J-P, Swanepoel R. 2005. Fruit bats as reservoirs of Ebola virus. Nature. 438:575–576.
   PubMed Web of Science ®Google Scholar
• Leroy EM, Rouquet P, Formenty P, Souquière S, Kilbourne A, Froment J-M, Bermejo M, Smit S, Karesh W, Swanepoel R, et al. 2004. Multiple Ebola virus transmission events and rapid decline of central African wildlife. Science. 303:387–390.
   PubMed Web of Science ®Google Scholar
• Leski TA, Ansumana R, Taitt CR, Lamin JM, Bangura U, Lahai J, Mbayo G, Kanneh MB, Bawo B, Bockarie AS, et al. 2015. Use of the FilmArray system for detection of Zaire ebolavirus in a SmallHospital in Bo, Sierra Leone. J Clin Microbiol. 53:2368–2370.
   PubMed Web of Science ®Google Scholar
• Liu L, Sun Y, Kargbo B, Zhang C, Feng H, Lu H, Liu W, Wang C, Hu Y, Deng Y, et al. 2014. Detection of Zaire Ebola virus by real-time reverse transcription-polymerase chain reaction, Sierra Leone, 2014. J Virol Methods. 222:62–65.
   Web of Science ®Google Scholar
• Liu Y, Shi ZX, Ma YK, Wang HT, Wang ZY, Shao DH, Wei JC, Wang SH, Li BB, Wang SM, et al. 2012. Development of SYBR Green I real-time RT-PCR for the detection of Ebola virus. Bing Du Xue Bao. 28:567–571.
   PubMedGoogle Scholar
• Lovgren Bengtsson K, Morein B, Osterhaus AD. 2011. ISCOM technology-based Matrix M adjuvant: success in future vaccines relies on formulation. Expert Rev Vaccines. 10:401–403
   PubMed Web of Science ®Google Scholar
• Lucht A, Formenty P, Feldmann H, Gotz M, Leroy E, Bataboukila P, Grolla A, Feldmann F, Wittmann T, Campbell P, et al. 2007. Development of an immunofiltration-based antigen-detection assay for rapid diagnosis of Ebola virus infection. J Infect Dis. 196:S184–S192.
   PubMed Web of Science ®Google Scholar
• Lucht A, Grunow R, Otterbein C, Möller P, Feldmann H, Becker S. 2004. Production of monoclonal antibodies and development of an antigen capture ELISA directed against the envelope glycoprotein GP of Ebola virus. Med Microbiol Immunol. 193:181–187.
   PubMed Web of Science ®Google Scholar
• Lüdtke A, Ruibal P, Becker-Ziaja B, Rottstegge M, Wozniak DM, Cabeza-Cabrerizo M, Thorenz A, Weller R, Kerber R, Idoyaga J, et al. 2016. Ebola Virus disease is characterized by poor activation and reduced levels of circulating CD16+ monocytes. J Infect Dis. 214(S3):S275–S280.
   PubMed Web of Science ®Google Scholar
• M Alam El-Din H, A Loutfy S, Fathy N, H Elberry M, M Mayla A, Kassem S, Naqvi A. 2016. Molecular docking based screening of compounds against VP40 from Ebola virus. Bioinformation. 12:192–196.
   PubMedGoogle Scholar
• MacNeil A, Farnon EC, Morgan OW, Gould P, Boehmer TK, Blaney DD, Wiersma P, Tappero JW, Nichol ST, Ksiazek TG, Rollin PE. 2011. Filovirus outbreak detection and surveillance: lessons from Bundibugyo. J Infect Dis. 204:S761–S767.
   PubMed Web of Science ®Google Scholar
• Mackay IM, Arden KE. 2015. Ebola virus in the semen of convalescent men. Lancet Infect Dis. 15:149–150.
   PubMed Web of Science ®Google Scholar
• Madrid PB, Chopra S, Manger ID, Gilfillan L, Keepers TR, Shurtleff AC, Green CE, Iyer LV, Dilks HH, Davey RA, et al. 2013. A systematic screen of FDA-approved drugs for inhibitors of biological threat agents. PLoS One. 8:e60579.
   PubMed Web of Science ®Google Scholar
• Maganga GD, Kapetshi J, Berthet N, Kebela Ilunga B, Kabange F, Mbala Kingebeni P, Mondonge V, Muyembe J-JT, Bertherat E, Briand S, et al. 2014. Ebola virus disease in the Democratic Republic of Congo. N Engl J Med. 371:2083–2091.
   PubMed Web of Science ®Google Scholar
• Makino A, Kawaoka Y. 2009. Generation of vero cells expressing ebola virus glycoprotein. J Vet Med Sci. 71:505–507.
   PubMed Web of Science ®Google Scholar
• Malik YS, Sharma K, Jeena LM, Kumar N, Sircar S, Rajak KK, Dhama K. 2013. Toll-like receptors: the innate immune receptors with ingenious anti-viral paradigm. South Asian J Exp Biol. 3:207–213.
   Google Scholar
• Mann E, Streng S, Bergeron J, Kircher A. 2015. A review of the role of food and the food system in the transmission and spread of Ebolavirus. PLoS Negl Trop Dis. 9:e0004160.
   PubMed Web of Science ®Google Scholar
• Maras MH, Miranda MD. 2016. The weaponization of Ebola: a new risk in the wake of an outbreak? Comp Strategy. 35:72–79.
   Google Scholar
• Martins KA, Jahrling PB, Bavari S, Kuhn JH. 2016. Ebola Virus disease candidate vaccines under evaluation in clinical trials. Expert Rev Vaccines. 15:1101–1112.
   PubMed Web of Science ®Google Scholar
• Mate SE, Kugelman JR, Nyenswah TG, Ladner JT, Wiley MR, Cordier-Lassalle T, Christie A, Schroth GP, Gross SM, Davies-Wayne GJ, et al. 2015. Molecular evidence of sexual transmission of Ebola virus. N Engl J Med. 373:2448–2454.
   PubMed Web of Science ®Google Scholar
• Mattia JG, Vandy MJ, Chang JC, Platt DE, Dierberg K, Bausch DG, Brooks T, Conteh S, Crozier I, Fowler RA, et al. 2016. Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study. Lancet Infect Dis. 16:331–338.
   PubMed Web of Science ®Google Scholar
• McCormick JB, Bauer SP, Elliott LH, Webb PA, Johnson KM. 1983. Biologic differences between strains of Ebola virus from Zaire and Sudan. J Infect Dis. 147:264–267.
   PubMed Web of Science ®Google Scholar
• McElroy AK, Akondy RS, Davis CW, Ellebedy AH, Mehta AK, Kraft CS, Lyon GM, Ribner BS, Varkey J, Sidney J, et al. 2015. Human Ebola virus infection results in substantial immune activation. Proc Natl Acad Sci. 112:4719–4724.
   PubMed Web of Science ®Google Scholar
• McElroy AK, Erickson BR, Flietstra TD, Rollin PE, Nichol ST, Towner JS, Spiropoulou CF. 2014. Ebola hemorrhagic fever: novel biomarker correlates of clinical outcome. J Infect Dis. 210:558–566.
   PubMed Web of Science ®Google Scholar
• Mendoza EJ, Qiu X, Kobinger GP. 2015. Progression of Ebola therapeutics during the 2014–outbreak. Trends Mol Med. 22:164–173
   Web of Science ®Google Scholar
• Miller LA, Stanger E, Senesi RG, DeLuca N, Dietz P, Hausman L, Kilmarx PH, Mermin J. 2015. Centers for Disease Control and Prevention. Use of a nationwide call center for Ebola response and monitoring during a 3-day house-to-house campaign -Sierra Leone, September 2014. MMWR Morb Mortal Wkly Rep. 64:28–29.
   PubMed Web of Science ®Google Scholar
• Miranda ME, White ME, Dayrit MM, Hayes CG, Ksiazek TG, Burans JP. 1991. Seroepidemiological study of filovirus related to Ebola in the Philippines. Lancet. 337:425–426.
   PubMed Web of Science ®Google Scholar
• Miranda MEG, Miranda NLJ. 2011. Reston ebolavirus in humans and animals in the Philippines: a review. J Infect Dis. 204:S757–S760.
   PubMed Web of Science ®Google Scholar
• Mire CE, Geisbert JB, Agans KN, Thi EP, Lee AC, Fenton KA, Geisbert TW. 2016. Passive immunotherapy: assessment of convalescent serum against Ebola virus Makona infection in nonhuman primates. J Infect Dis. 214(S3):S367–S374.
   Web of Science ®Google Scholar
• Mire CE, Geisbert JB, Marzi A, Agans KN, Feldmann H, Geisbert TW. 2013. Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus. PLoS Negl Trop Dis. 7:e2600.
   PubMed Web of Science ®Google Scholar
• Mishra B. 2014. The threat of Ebola: an update. Ind J Med Microbiol. 32:364–370.
   PubMed Web of Science ®Google Scholar
• Morvan JM, Deubel V, Gounon P, Nakouné E, Barrière P, Murri S, Perpète O, Selekon B, Coudrier D, Gautier-Hion A, et al. 1999. Identification of Ebola virus sequences present as RNA or DNA in organs of terrestrial small mammals of the Central African Republic. Microbes Infect. 1:1193–1201.
   PubMed Web of Science ®Google Scholar
• Mufunda J, Ndambakuwa Y, Muno-dawafa D, Kobie A. 2016. Is a total ban on business and consumption of bush-meat a sustainable end game for eb-ola outbreak in West Africa: but why now. Public Health Open J. 1:4–7.
   Google Scholar
• Muhlberger E, Weik M, Volchkov VE, Klenk HD, Becker S. 1999. Comparison of the transcription and replication strategies of Marburg virus and Ebola virus by using artificial replication systems. J Virol. 73:2333–2342.
   PubMed Web of Science ®Google Scholar
• Muyembe-Tamfum JJ, Kipasa M, Kiyungu C, Colebunders R. 1999. Ebola outbreak in Kikwit, Democratic Republic of the Congo: discovery and control measures. J Infect Dis. 179:S259–262.
   PubMed Web of Science ®Google Scholar
• Muyembe-Tamfum JJ, Mulangu S, Masumu J, Kayembe JM, Kemp A, Paweska JT. 2012. Ebola virus outbreaks in Africa: past and present. Onderstepoort J Vet Res. 79:451.
   PubMed Web of Science ®Google Scholar
• Nagata T, Lefor AK, Hasegawa M, Ishii M. 2015. Favipiravir: a new medication for the Ebola virus disease pandemic. Disaster Med Public Health Prep. 9:79–81.
   PubMed Web of Science ®Google Scholar
• Nei M, Kumar S. 2000. Molecular evolution and phylogenetics. New York, NY: Oxford University Press.
   Google Scholar
• Nkoghe D, Formenty P, Leroy EM, Nnegue S, Edou SYO, Ba JI, Allarangar Y, Cabore J, Bachy C, Andraghetti R, et al. 2005. Multiple Ebola virus haemorrhagic fever outbreaks in Gabon, from October 2001 to April 2002. Bull Soc Pathol Exot. 98:224–229.
   PubMedGoogle Scholar
• Nkoghe D, Nnegue S, Mve MT, Formenty P, Thompson G, Iba Ba J, Okome Nkoumou M, Leroy E. 2005. Isolated case of haemorrhagic fever observed in Gabon during the 2002 outbreak of Ebola but distant from epidemic zones. Médecine Trop Rev Corps Santé Colon. 65:349–354.
   PubMedGoogle Scholar
• Noda T, Sagara H, Suzuki E, Takada A, Kida H, Kawaoka Y. 2002. Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. J Virol. 76:4855–4865.
   PubMed Web of Science ®Google Scholar
• Nordenstedt H, Bah EI, de la Vega MA, Barry M, N'Faly M, Barry M, Crahay B, Decroo T, Van Herp M, Ingelbeen B. 2016. Ebola virus in breast milk in an ebola virus-positive mother with twin babies, Guinea, 2015. Emerg Infect Dis. 22:759–760.
   PubMed Web of Science ®Google Scholar
• Nouvellet P, Garske T, Mills HL, Nedjati-Gilani G, Hinsley W, Blake IM, Van Kerkhove MD, Cori A, Dorigatti I, Jombart T, et al. 2015. The role of rapid diagnostics in managing Ebola epidemics. Nature. 528:S109–S116.
   PubMed Web of Science ®Google Scholar
• Nyamathi AM, Fahey JL, Sands H, Casillas AM. 2003. Ebola virus: immune mechanisms of protection and vaccine development. Biol Res Nurs. 4:276–281.
   PubMedGoogle Scholar
• Oestereich L, Ludtke A, Wurr S, Rieger T, Muñoz-Fontela C, Gunther S. 2014. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model. Antiviral Res. 105:17–21.
   PubMed Web of Science ®Google Scholar
• Okeke IN, Manning RS, Pfeiffer T. 2014. Diagnostic schemes for reducing epidemic size of African viral hemorrhagic fever outbreaks. J Infect Dev Ctries. 8:1148–1159.
   PubMed Web of Science ®Google Scholar
• Okware SI, Omaswa F, Talisuna A, Amandua J, Amone J, Onek P, Opio A, Warnala J, Lubwama J, Luswa L, et al. 2015. Managing Ebola from rural to urban slum settings: experiences from Uganda. Afr Health Sci. 15:312–321.
   PubMed Web of Science ®Google Scholar
• Okware SI, Omaswa FG, Zaramba S, Opio A, Lutwama JJ, Kamugisha J, Rwaguma EB, Kagwa P, Lamunu M. 2002. An outbreak of Ebola in Uganda. Trop Med Int Health. 7:1068–1075.
   PubMed Web of Science ®Google Scholar
• Olejnik J, Ryabchikova E, Corley RB, Muhlberger E. 2011. Intracellular events and cell fate in filovirus infection. Viruses 3:1501–1531.
   PubMed Web of Science ®Google Scholar
• Olival KJ, Islam A, Yu M, Anthony SJ, Epstein JH, Khan SA, Khan SU, Crameri G, Wang LF, Lipkin WI, et al. 2013. Ebola virus antibodies in fruit bats, Bangladesh. Emerg Infect Dis. 19:270.
   PubMed Web of Science ®Google Scholar
• Olsen NJ, Schleich MA, Karp DR. 2013. Multifaceted effects of hydroxychloroquine in human disease. Semin Arthritis Rheum. 43:264–272.
   PubMed Web of Science ®Google Scholar
• Olupot-Olupot P. 2015. Ebola in children: epidemiology, clinical features, diagnosis and outcomes. Pediatr Infect Dis J. 34:314–316.
   PubMed Web of Science ®Google Scholar
• Osterholm MT, Moore KA, Kelley NS, Brosseau LM, Wong G, Murphy FA, Peters CJ, LeDuc JW, Russell PK, Van Herp M, et al. 2015. Transmission of Ebola viruses: what we know and what we do not know. MBio. 6:e00137.
   PubMed Web of Science ®Google Scholar
• Pan Y, Zhang W, Cui L, Hua X, Wang M, Zeng Q. 2014. Reston virus in domestic pigs in China. Arch Virol. 159:1129–1132.
   PubMed Web of Science ®Google Scholar
• Pang Z, Li A, Li J, Qu J, He C, Zhang S, Li C, Zhang Q, Liang M, Li D. 2014. Comprehensive multiplex one-step real-time TaqManqRT-PCR assays for detection and quantification of hemorrhagic fever viruses. PLoS One. 9:e95635.
   PubMed Web of Science ®Google Scholar
• Pennisi EG. 2016. Pocket DNA sequencers make real-time diagnostics a reality. Science. 351:800–801.
   PubMed Web of Science ®Google Scholar
• Pettitt J, Higgs ES, Adams RD, Jahrling PB, Hensley LE. 2016. Use of existing diagnostic reverse-transcription polymerase chain reaction assays for detection of ebola virus RNA in semen. J Infect Dis. 213:1237–1239.
   PubMed Web of Science ®Google Scholar
• Piercy TJ, Smither SJ, Steward JA, Eastaugh L, Lever MS. 2010. The survival of filoviruses in liquids, on solid substrates and in a dynamic aerosol. J Appl Microbiol. 109:1531–1539.
   PubMed Web of Science ®Google Scholar
• Pigott DM, Golding N, Mylne A, Huang Z, Henry AJ, Weiss DJ, Brady OJ, Kraemer MU, Smith DL, Moyes CL, et al. 2014. Mapping the zoonotic niche of Ebola virus disease in Africa. Elife. 7:e04395.
   Google Scholar
• Pinsky BA, Sahoo MK, Sandlund J, Kleman M, Kulkarni M, Grufman P, Nygren M, Kwiatkowski R, Baron EJ, Tenover F, et al. 2015. Analytical performance characteristics of the cepheid GeneXpert Ebola assay for the detection of Ebola virus. PLoS One. 10:e0142216.
   PubMed Web of Science ®Google Scholar
• Pleet ML, DeMarino C, Lepene B, Aman MJ, Kashanchi F. 2017. The Role of exosomal VP40 in Ebola virus disease. DNA Cell Biol. doi: 10.1089/dna.2017.3639.
   PubMed Web of Science ®Google Scholar
• Pourrut X, Délicat A, Rollin PE, Ksiazek TG, Gonzalez JP, Leroy EM. 2007. Spatial and temporal patterns of Zaire ebolavirus antibody prevalence in the possible reservoir bat species. J Infect Dis. 196:S176–S183.
   PubMed Web of Science ®Google Scholar
• Pourrut X, Kumulungui B, Wittmann T, Moussavou G, Délicat A, Yaba P, Nkoghe D, Gonzalez JP, Leroy EM. 2005. The natural history of Ebola virus in Africa. Microbes Infect. 7:1005–1014.
   PubMed Web of Science ®Google Scholar
• Pourrut X, Souris M, Towner JS, Rollin PE, Nichol ST, Gonzalez J-P, Leroy E. 2009. Large serological survey showing cocirculation of Ebola and Marburg viruses in Gabonese bat populations, and a high seroprevalence of both viruses in Rousettus aegyptiacus. BMC Infect Dis. 9:159.
   PubMed Web of Science ®Google Scholar
• Purpura LJ, Soka M, Baller A, White S, Rogers E, Choi MJ, Mahmoud N, Wasunna C, Massaquoi M, Vanderende K, et al. 2016. Implementation of a national semen testing and counseling program for male Ebola survivors - Liberia, 2015-2016. Morb Mortal Wkly Rep. 65:963–966.
   Google Scholar
• Pushko P, Bray M, Ludwig GV, Parker M, Schmaljohn A, Sanchez A, Jahrling PB, Smith JF. 2003. Ebola virus-like particles protect from lethal Ebola virus infection. Proc Natl Acad Sci. 100:15889e94.
   Web of Science ®Google Scholar
• Qiu X, Fernando L, Alimonti JB, Melito PL, Feldmann F, Dick D, Ströher U, Feldmann H, Jones SM. 2009. Mucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responses. PLoS One. 4:e5547.
   PubMed Web of Science ®Google Scholar
• Quaglio G, Goerens C, Putoto G, Rübig P, Lafaye P, Karapiperis T, Dario C, Delaunois P, Zachariah R. 2016. Ebola: lessons learned and future challenges for Europe. Lancet Infect Dis. 16:259–263.
   PubMed Web of Science ®Google Scholar
• Quick J, Loman NJ, Duraffour S, Simpson JT, Severi E, Cowley L, Bore JA, Koundouno R, Dudas G, Mikhail A, et al. 2016. Real-time, portable genome sequencing for Ebola surveillance. Nature. 530:228–232.
   PubMed Web of Science ®Google Scholar
• Qureshi AI, Chughtai M, Loua TO, Pe Kolie J, Camara HFS, Ishfaq MF, N'Dour CT, Beavogui K. 2015. Study of Ebola virus disease survivors in Guinea. Clin Infect Dis. 61:1035–1042.
   PubMed Web of Science ®Google Scholar
• Racsa LD, Kraft CS, Olinger GG, Hensley LE. 2016. Viral hemorrhagic fever diagnostics. Clin Infect Dis. 62:214–219.
   PubMed Web of Science ®Google Scholar
• Read JM, Diggle PJ, Chirombo J, Solomon T, Baylis M. 2015. Effectiveness of screening for Ebola at airports. The Lancet. 385:23–24.
   PubMed Web of Science ®Google Scholar
• Reed DS, Lackemeyer MG, Garza NL, Sullivan LJ, Nichols DK. 2011. Aerosol exposure to Zaire ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology. Microbes Infect. 13:930–936.
   PubMed Web of Science ®Google Scholar
• Report of a WHO/International Study Team. 1978. Ebola haemorrhagic fever in Sudan, 1976. Bull World Health Organ. 56:247–270.
   PubMed Web of Science ®Google Scholar
• Report of an International Commission. 1978. Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ. 56:271–293.
   PubMed Web of Science ®Google Scholar
• Rewar S, Mirdha D. 2014. Transmission of ebola virus disease: an overview. Ann Glob Health. 80:444–451.
   PubMed Web of Science ®Google Scholar
• Richman DD, Cleveland PH, McCormick JB, Johnson KM. 1983. Antigenic analysis of strains of Ebola virus: identification of two Ebola virus serotypes. J Infect Dis. 147:268–271.
   PubMed Web of Science ®Google Scholar
• Roels TH, Bloom AS, Buffington J, Muhungu GL, Mac Kenzie WR, Khan AS, Ndambi R, Noah DL, Rolka HR, Peters CJ, Ksiazek TG. 1999. Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure. J Infect Dis. 179:S92–S97.
   PubMed Web of Science ®Google Scholar
• Rollin PE, Williams RJ, Bressler DS, Pearson S, Cottingham M, Pucak G, Sanchez A, Trappier SG, Peters RL, Greer PW, et al. 1999. Ebola (subtype Reston) virus among quarantined nonhuman primates recently imported from the Philippines to the United States. J Infect Dis. 179:S108–S114.
   PubMed Web of Science ®Google Scholar
• Rouquet P, Froment J-M, Bermejo M, Kilbourn A, Karesh W, Reed P, Kumulungui B, Yaba P, Délicat A, Rollin PE, Leroy EM. 2005. Wild animal mortality monitoring and human Ebola outbreaks, Gabon and Republic of Congo, 2001-2003. Emerg Infect Dis. 11:283–290.
   PubMed Web of Science ®Google Scholar
• Rowe AK, Bertolli J, Khan AS, Mukunu R, Muyembe-Tamfum JJ, Bressler D, Williams AJ, Peters CJ, Rodriguez L, Feldmann H, et al. 1999. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis. 179:S28–S35.
   PubMed Web of Science ®Google Scholar
• Safari S, Baratloo A, Rouhipour A, Ghelichkhani P, Mamood Yousefifard M. 2015. Ebola hemorrhagic fever as a public health emergency of international concern; a review article. Emerg (Tehran). 3:3–7.
   PubMedGoogle Scholar
• Saitou N, Nei M. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evolut. 4:406–425.
   PubMed Web of Science ®Google Scholar
• Sakurai Y, Kolokoltsov AA, Chen CC, Tidwell MW, Bauta WE, Klugbauer N, Grimm C, Wahl-Schott C, Biel M, Davey RA. 2015. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment. Science. 347:995–998.
   PubMed Web of Science ®Google Scholar
• Salman M, Shehzadi N, Hussain K, Saleem F, Khan MT, Asif N, Yousaf M, Rafique M, Bedar R, Tariq S, et al. 2017. Knowledge of Ebola virus disease among a university population: a cross-sectional study. Am J Infect Control. 45:e23–e25.
   PubMed Web of Science ®Google Scholar
• Sanchez A, Kiley MP, Holloway BP, Auperin DD. 1993. Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus. Virus Res. 29:215–240.
   PubMed Web of Science ®Google Scholar
• Sanchez A, Ksiazek TG, Rollin PE, Miranda ME, Trappier SG, Khan AS, Peters CJ, Nichol ST. 1999. Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates. J Infect Dis. 179:S164–S169.
   PubMed Web of Science ®Google Scholar
• Sanchez A. 2007. Analysis of filovirus entry into vero E6 cells, using inhibitors of endocytosis, endosomal acidification, structural integrity, and cathepsin (B and L) activity. J Infect Dis. 196:S251–S258.
   PubMed Web of Science ®Google Scholar
• Saphire EO. 2013. An update on the use of antibodies against the filoviruses. Immunotherapy. 5:1221–1233.
   PubMed Web of Science ®Google Scholar
• Saphire EO. 2015. New advances in the effort against Ebola. Cell Host Microbe. 17:545–547.
   PubMed Web of Science ®Google Scholar
• Sarwar UN, Costner P, Enama ME, Berkowitz N, Hu Z, Hendel CS, Sitar S, Plummer S, Mulangu S, Bailer RT, et al. 2015. Safety and immunogenicity of DNA vaccines encoding Ebolavirus and Marburgvirus wild-type glycoproteins in a phase I clinical trial. J Infect Dis. 211:549–557
   PubMed Web of Science ®Google Scholar
• Scott JT, Sesay FR, Massaquoi TA, Idriss BR, Sahr F, Semple MG. 2016. Post-Ebola syndrome, Sierra Leone. Emerg Infect Dis. 22:641–646.
   PubMed Web of Science ®Google Scholar
• Shabman RS, Leung DW, Johnson J, Glennon N, Gulcicek EE, Stone KL, Leung L, Hensley L, Amarasinghe GK, Basler CF. 2011. DRBP76 associates with Ebola virus VP35 and suppresses viral polymerase function. J Infect Dis. 204:S911–S918.
   PubMed Web of Science ®Google Scholar
• Shah NR, Sharma S, Waters L, Arango C, Scuderi C. 2015. Ebola virus disease: an update on diagnosis, treatment, and prevention. Consultant. 55:988–994.
   Google Scholar
• Shantha JG, Crozier I, Hayek BR, Bruce BB, Gargu C, Brown J, Fankhauser J, Yeh S. 2017. Ophthalmic manifestations and causes of vision impairment in Ebola virus disease survivors in Monrovia, Liberia. Ophthalmology. 124:170–177.
   PubMed Web of Science ®Google Scholar
• Shantha JG, Crozier I, Varkey JB, Kraft CS, Lyon GM, Mehta AK, Carlson RD, Hill CE, Kumar G, Debiec MR, et al. 2016. Long-term management of panuveitis and Iris heterochromia in an Ebola survivor. Ophthalmology 123:2626–2628.e2.
   PubMed Web of Science ®Google Scholar
• Sheng M, Zhong Y, Chen Y, Du J, Ju X, Zhao C, Zhang G, Zhang L, Liu K, Yang N, et al. 2014. Hsa-miR-1246, hsa-miR-320a and hsa-miR-196b-5p inhibitors can reduce the cytotoxicity of Ebola virus glycoprotein in vitro. Sci China Life Sci. 57:959–972.
   PubMed Web of Science ®Google Scholar
• Sherwood LJ, Osborn LE, Carrion R Jr, Patterson JL, Hayhurst A. 2007. Rapid assembly of sensitive antigen-capture assays for Marburg virus, using in vitro selection of llama single-domain antibodies, at biosafety level 4. J Infect Dis. 196:S213–S219.
   PubMed Web of Science ®Google Scholar
• Shi M, Shen YQ. 2013. Research progress of the molecule mechanisms of Ebola virus infection of cells. Bing Du Xue Bao. 29:71–75.
   PubMedGoogle Scholar
• Shoemaker T, MacNeil A, Balinandi S, Campbell S, Wamala JF, McMullan LK, Downing R, Lutwama J, Mbidde E, Ströher U, et al. 2012. Reemerging Sudan Ebola virus disease in Uganda, 2011. Emerg Infect Dis. 18:1480–1483.
   PubMed Web of Science ®Google Scholar
• Shrivastava SR, Shrivastava PS, Ramasamy J. 2015a. Ebola disease: an international public health emergency. Asian Pacific J Trop Dis. 5:253–262.
   Google Scholar
• Shrivastava SR, Shrivastava PS, Ramasamy J. 2015b. Lessons learnt from the 2014 Ebola outbreak in West-Africa. J Res Med Sci. 20:107–108.
   PubMed Web of Science ®Google Scholar
• Shrivastava SR, Shrivastava PS, Ramasamy J. 2016. Ebola-free Liberia: scrutinizing the efforts of public health sector and international agencies. Int J Prev Med. 7:1.
   PubMed Web of Science ®Google Scholar
• Singh RK, Badasara SK, Dhama K, Malik YPS. 2015. Progress and prospects in vaccine research. Chapter in National Workshop on “Current Trends and Future Research Challenges in Vaccines and Adjuvants”. Organized at ICAR Indian Veterinary Research Institute, Izatnagar 243122, Bareilly, Uttar Pradesh, India during 19‐20 November 2015, p. 1–19.
   Google Scholar
• Sissoko D, Laouenan C, Folkesson E, M'Lebing AB, Beavogui AH, Baize S, Camara AM, Maes P, Shepherd S, Danel C, et al. 2016. Experimental treatment with favipiravir for Ebola virus disease (the JIKI Trial): a historically controlled, single-arm proof-of-concept trial in Guinea. PLoS Med. 13:e1001967.
   PubMed Web of Science ®Google Scholar
• Skiadopoulos MH, Surman SR, Riggs JM, Orvell C, Collins PL, Murphy BR. 2002. Evaluation of the replication and immunogenicity of recombinant human parainfluenza virus type 3 vectors expressing up to three foreign glycoproteins. Virology. 297:136–152.
   PubMed Web of Science ®Google Scholar
• Smither SJ, Eastaugh LS, Steward JA, Nelson M, Lenk RP, Lever MS. 2014. Post-exposure efficacy of oral T-705 (favipiravir) against inhalational Ebola virus infection in a mouse model. Antiviral Res. 104:153–155.
   PubMed Web of Science ®Google Scholar
• Spengler JR, Chakrabarti AK, Coleman-McCray JD, Martin BE, Nichol ST, Spiropoulou CF, Bird BH. 2015. Utility of oral swab sampling for Ebola virus detection in guinea pig model. Emerg Infect Dis. 21:1816–1819.
   PubMed Web of Science ®Google Scholar
• Spengler JR, Ervin ED, Towner JS, Rollin P, Nichol S. 2016. Comments to author perspectives on West Africa Ebola virus disease outbreak, 2013–2016. Emerg Infect Dis. 22:956–963.
   PubMed Web of Science ®Google Scholar
• Sridhar S. 2015. Clinical development of Ebola vaccines. Ther Adv Vaccines. 3:125–138.
   PubMedGoogle Scholar
• Stamm LV. 2015. Ebola virus disease: rapid diagnosis and timely case reporting are critical to the early response for outbreak control. Am J Trop Med Hyg. 93:438–440.
   PubMed Web of Science ®Google Scholar
• Steele K, Crise B, Kuehne A, Kell W. 2001. Ebola virus glycoprotein demonstrates differential cellular localization in infected cell types of nonhuman primates and Guinea Pigs. Arch Pathol Lab Med. 125:625–630.
   PubMed Web of Science ®Google Scholar
• Stephens KW, Hutchins RJ, Dauphin LA. 2010. Cross-platform evaluation of commercial real-time reverse transcription PCR master mix kits using a quantitative 5’ nuclease assay for Ebola virus. Mol Cell Probes. 24:370–375.
   PubMed Web of Science ®Google Scholar
• Streatfield SJ, Kushnir N, Yusibov V. 2015. Plant-produced candidate countermeasures against emerging and reemerging infections and bioterror agents. Plant Biotechnol J. 13:1136–1159.
   PubMed Web of Science ®Google Scholar
• Sullivan NJ, Martin JE, Graham BS, Nabel GJ. 2009. Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule. Nat Rev Microbiol. 7:393–400.
   PubMed Web of Science ®Google Scholar
• Sun G, Miyata K, Matsuoka A, Zhao Z, Iwakami S, Kim S, Matsui T. 2015. A compact and hand-held infection-screening system for use in rapid medical inspection at airport quarantine stations: system design and preliminary validation. J Med Eng Technol. 39:185–190.
   PubMedGoogle Scholar
• Suzuki Y, Gojobori T. 1997. The origin and evolution of Ebola and Marburg viruses. Mol Biol Evol. 14:800–806.
   PubMed Web of Science ®Google Scholar
• Swanepoel R, Leman PA, Burt FJ, Zachariades NA, Braack LE, Ksiazek TG, Rollin PE, Zaki SR, Peters CJ. 1996. Experimental inoculation of plants and animals with Ebola virus. Emerg Infect Dis. 2:321.
   PubMed Web of Science ®Google Scholar
• Takada A, Kawaoka Y. 2001. The pathogenesis of Ebola hemorrhagic fever. Trends Microbiol. 9:506–511.
   PubMed Web of Science ®Google Scholar
• Tambo E, Ugwu EC, Ngogang JY. 2014. Need of surveillance response systems to combat Ebola outbreaks and other emerging infectious diseases in African countries. Infect Dis Pov. 3:29.
   PubMed Web of Science ®Google Scholar
• Tamura K, Nei M, Kumar S. 2004. Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc Nat Acad Sci (USA). 101:11030–11035.
   PubMed Web of Science ®Google Scholar
• Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. 2013. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evolut. 30:2725–2729.
   PubMed Web of Science ®Google Scholar
• Taniguchi S, Watanabe S, Masangkay JS, Omatsu T, Ikegami T, Alviola P, Ueda N, Iha K, Fujii H, Ishii Y, et al. 2011. Reston ebolavirus antibodies in bats, the Philippines. Emerg Infect Dis. 17:1559–1560.
   PubMed Web of Science ®Google Scholar
• Taylor DJ, Dittmar K, Ballinger MJ, Bruenn JA. 2011. Evolutionary maintenance of filovirus-like genes in bat genomes. BMC Evol Biol. 11:336.
   PubMed Web of Science ®Google Scholar
• Team WER. 2015. Ebola virus disease among children in West Africa. N Engl J Med. 372:1274–1277.
   Web of Science ®Google Scholar
• Team WER. 2016. Ebola Virus disease among male and female persons in West Africa. N Engl J Med. 374:96–98.
   PubMed Web of Science ®Google Scholar
• Teimoori S, Seesuay W, Jittavisutthikul S, Chaisri U, Sookrung N, Densumite J, Saelim N, Chulanetra M, Maneewatch S, Chaicumpa W. 2016. Human transbodies to VP40 inhibit cellular egress of Ebola virus-like particles. Biochem Bioph Res Co. 479:245–252.
   PubMed Web of Science ®Google Scholar
• Thi EP, Mire CE, Lee AC, Geisbert JB, Zhou JZ, Agans KN, Snead NM, Deer DJ, Barnard TR, Fenton KA, et al. 2015. Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates. Nature. 521:362–365.
   PubMed Web of Science ®Google Scholar
• Thorson A, Formenty P, Lofthouse C, Broutet N. 2016. Systematic review of the literature on viral persistence and sexual transmission from recovered Ebola survivors: evidence and recommendations. BMJ Open. 6:e008859.
   PubMed Web of Science ®Google Scholar
• Toit AD. 2014. Ebola virus in West Africa. Nat Rev Microbiol. 12:312.
   Google Scholar
• Towner JS, Pourrut X, Albarino CG, Nkogue CN, Bird BH, Grard G, Ksiazek TG, Gonzalez JP, Nichol ST, Leroy EM. 2007. Marburg virus infection detected in a common African bat. PLoS One. 2:e764.
   PubMed Web of Science ®Google Scholar
• Towner JS, Rollin PE, Bausch DG, Sanchez A, Crary SM, Vincent M, Lee WF, Spiropoulou CF, Ksiazek TG, Lukwiya M, et al. 2004. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol. 78:4330–4341.
   PubMed Web of Science ®Google Scholar
• Towner JS, Sealy TK, Khristova ML, Albariño CG, Conlan S, Reeder SA, Quan P-L, Lipkin WI, Downing R, Tappero JW, et al. 2008. Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog. 4:e1000212.
   PubMed Web of Science ®Google Scholar
• Tracey LE, Regan AK, Armstrong PK, Dowse GK, Effler PV. 2015. EbolaTracks: an automated SMS system for monitoring persons potentially exposed to Ebola virus disease. Euro Surveill. 20:20999.
   PubMedGoogle Scholar
• Truant AL, Regnery RL, Kiley MP. 1983. Development of an immunofluorescence focus assay for Ebola virus. J Clin Microbiol. 18:416–419.
   PubMed Web of Science ®Google Scholar
• Tsang MK, Ye W, Wang G, Li J, Yang M, Hao J. 2016. Ultrasensitive detection of ebola virus oligonucleotide based on upconversionnanoprobe/nanoporous membrane system. ACS Nano. 10:598–605.
   PubMed Web of Science ®Google Scholar
• Tsuda Y, Parkins CJ, Caposio P, Feldmann F, Botto S, Ball S, Messaoudi I, Cicin-Sain L, Feldmann H, Jarvis MA. 2015. A cytomegalovirus-based vaccine provides long-lasting protection against lethal Ebola virus challenge after a single dose. Vaccine. 33:2261–2266.
   PubMed Web of Science ®Google Scholar
• Uyeki TM, Mehta AK, Davey RT Jr, Liddell AM, Wolf T, Vetter P, Schmiedel S, Grünewald T, Jacobs M, Arribas JR, et al. 2016. Working Group of the U.S.– European clinical network on clinical management of ebola virus disease patients in the U.S. and Europe. Clinical management of ebola virus disease in the United States and Europe. N Engl J Med. 374:636–646.
   PubMed Web of Science ®Google Scholar
• Van der Groen G, Pattyn SR. 1979. Measurement of antibodies to Ebola virus in human sera from N. W.-Zaire. Ann Soc Belg Med Trop. 59:87–92.
   PubMedGoogle Scholar
• Varkey JB, Shantha JG, Crozier I, Kraft CS, Lyon GM, Mehta AK, Kumar G, Smith JR, Kainulainen MH, Whitmer S, et al. 2015. Persistence of ebola virus in ocular fluid during convalescence. N Engl J Med. 372:2423.
   PubMed Web of Science ®Google Scholar
• Villinger F, Rollin PE, Brar SS, Chikkala NF, Winter J, Sundstrom J, Zaki SR, Swanepoel R, Ansari A, Peters CJ. 1999. Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis. 179:S188–S191.
   PubMed Web of Science ®Google Scholar
• Vogel WH, Viale PH. 2014. What you need to know about the Ebola virus. J Adv Pract Oncol. 5:471–473.
   PubMedGoogle Scholar
• Volchkov VE, Volchkova VA, Chepurnov AA, Blinov VM, Dolnik O, Netesov SV, Feldmann H. 1999. Characterization of the L gene and 5’ trailer region of Ebola virus. J Gen Virol. 80:355–362.
   PubMed Web of Science ®Google Scholar
• WHO. 1992. Viral haemorrhagic fever in imported monkeys. Wkly Epidemiol Rec. 67:142–143.
   PubMedGoogle Scholar
• WHO. 1996. Ebola haemorrhagic fever – South Africa. Wkly Epidemiol Rec. 71:359.
   Google Scholar
• WHO. 2003. Outbreak(s) of Ebola haemorrhagic fever, Congo and Gabon, October 2001-July 2002. Wkly Epidemiol Rec. 78:223–228.
   PubMedGoogle Scholar
• WHO. 2005. Outbreak of Ebola haemorrhagic fever in Yambio, south Sudan, April - June 2004. Wkly Epidemiol Rec. 80:370–375.
   PubMedGoogle Scholar
• WHO. 2009. WHO experts consultation on Ebola Reston pathogenicity in humans [Internet]. [cited 2016 Mar 17]. Available from: http://apps.who.int/iris/handle/10665/130162.
   Google Scholar
• WHO. 2014. WHO emergency quality assessment mechanism for EVD IVDs. Public report. Product: RealStarR Filovirus Screen RT-PCR Kit 1.0. Available from: www.who.int/diagnostics_laboratory/procurment/141125
   Google Scholar
• WHO Ebola Response Team. 2014. Ebola virus disease in West Africa-the first 9 months of the epidemic and forward projections. N Engl J Med. 371:1481–1495.
   PubMed Web of Science ®Google Scholar
• WHO Ebola Response Team. 2016. Ebola virus disease among male and female persons in West Africa. N Engl J Med. 374:96–98.
   PubMed Web of Science ®Google Scholar
• Walker NF, Whitty CJ. 2015. Tackling emerging infections: clinical and public health lessons from the West African Ebola virus disease outbreak, 2014-2015. Clin Med (Lond). 15:457–460.
   PubMed Web of Science ®Google Scholar
• Walsh KB, Teijaro JR, Wilker PR, Jatzek A, Fremgen DM, Das SC, Watanabe T, Hatta M, Shinya K, Suresh M, et al. 2011. Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus. Proc Natl Sci. 108:12018–12023.
   PubMed Web of Science ®Google Scholar
• Wang D, Raja NU, Trubey CM, Juompan LY, Luo M, Woraratanadharm J, Deitz SB, Yu H, Swain BM, Moore KM, et al. 2006. Development of a cAdVax-based bivalent Ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus. J Virol. 80:2738–2746.
   PubMed Web of Science ®Google Scholar
• Wang S, Zang L, Feng M, Liang Z, Wang S, Zheng S, Zhang L, Jiang Z, Chen D. 1997. Transmission electron microscopic study of the hemorrhagic spots in patients with epidemic hemorrhagic fever in the early stage. Ultrastruct Pathol. 21:281–287.
   PubMed Web of Science ®Google Scholar
• Wang SR, Zhang QY, Wang JQ, Ge XY, Song YY, Wang YF, Li XD, Fu BS, Xu GH, Shu B, et al. 2016. Chemical targeting of a G-quadruplex RNA in the Ebola virus L gene. Cell Chem Biol. 23(9):1113–1122.
   PubMed Web of Science ®Google Scholar
• Warren TK, Warfield KL, Wells J, Swenson DL, Donner KS, Van Tongeren SA, Garza NL, Dong L, Mourich DV, Crumley S, et al. 2010. Advanced antisense therapies for postexposure protection against lethal filovirus infections. Nat Med. 16:991–994.
   PubMed Web of Science ®Google Scholar
• Warren TK, Wells J, Panchal RG, Stuthman KS, Garza NL, Van Tongeren SA, Dong L, Retterer CJ, Eaton BP, Pegoraro G, et al. 2014. Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430. Nature. 508:402–405.
   PubMed Web of Science ®Google Scholar
• Warren TK, Whitehouse CA, Wells J, Welch L, Heald AE, Charleston JS, Sazani P, Reid SP, Iversen PL, Bavari S. 2015. A single phosphorodiamidate morpholino oligomer targeting VP24 protects rhesus monkeys against lethal Ebola virus infection. M Bio. 6:e02344–14.
   Google Scholar
• Wec AZ, Nyakatura EK, Herbert AS, Howell KA, Holtsberg FW, Bakken RR, Mittler E, Christin JR, Shulenin S, Jangra RK, et al. 2016. A “Trojan horse” bispecific antibody strategy for broad protection against ebolaviruses. Science. 354:350–354.
   PubMed Web of Science ®Google Scholar
• Weingart HM, Embury-Hyatt C, Nfon C, Leung A, Smith G, Kobinger G. 2012. Transmission of Ebola virus from pigs to non-human primates. Sci Rep. 2 :811.
   PubMed Web of Science ®Google Scholar
• Weingart lHM, Nfon C, Kobinger G. 2013. Review of Ebola virus infections in domestic animals. Dev Biol (Basel). 135:211–218.
   PubMedGoogle Scholar
• Weller SA, Bailey D, Matthews S, Lumley S, Sweed A, Ready D, Eltringham G, Richards J, Vipond R, Lukaszewski R, et al. 2016. Evaluation of the Biofire Film Array BioThreat-E Test (v2.5) for rapid identification of ebola virus disease in heat-treated blood samples obtained in Sierra Leone and the United Kingdom. J Clin Microbiol. 54:114–119.
   PubMed Web of Science ®Google Scholar
• Wendo C. 2001. Caring for the survivors of Uganda's Ebola epidemic one year on. Lancet. 358:1350.
   PubMed Web of Science ®Google Scholar
• Wiwanitkit V. 2016. Ebola and pregnancy. Obstetric Med.. 9:50.
   PubMed Web of Science ®Google Scholar
• Wolf T, Kann G, Becker S, Stephan C, Brodt H, de Leuw P, Grünewald T, Vogl T, Kempf VAJ, Keppler OT, Zacharowski K. 2015. Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care. Lancet. 385:1428–1435. doi: 10.1016/S0140-6736(14)62384-9.
   PubMed Web of Science ®Google Scholar
• Wong G, Kobinger GP, Qiu X. 2014. Characterization of host immune responses in Ebola virus infections. Expert Rev Clin Immunol. 10:781–790.
   PubMed Web of Science ®Google Scholar
• Wong G, Qiu X, Olinger GG, Kobinger GP. 2014. Post-exposure therapy of filovirus infections. Trends Microbiol. 22:456.
   PubMed Web of Science ®Google Scholar
• Woolhouse ME, Rambaut A, Kellam P. 2015. Lessons from Ebola: improving infectious disease surveillance to inform outbreak management. Sci Transl Med. 7:307rv5. Available from: http://www.bbc.com/news/magazine-28262541
   PubMed Web of Science ®Google Scholar
• Wyers M, Formenty P, Cherel Y, Guigand L, Fernandez B, Boesch C, Le Guenno B. 1999. Histopathological and immunohistochemical studies of lesions associated with Ebola virus in a naturally infected chimpanzee. J Infect Dis. 179:S54–S59.
   PubMed Web of Science ®Google Scholar
• Yang L, Sanchez A, Ward JM, Murphy BR, Collins PL, Bukreyev A. 2008. A paramyxovirus-vectored intranasal vaccine against Ebola virus is immunogenic in vector-immune animals. Virology. 377:255–264.
   PubMed Web of Science ®Google Scholar
• Yang Y, Bai L, Hu KX, Yang ZH, Hu JP, Wang J. 2012. Multiplex real-time PCR method for rapid detection of Marburg virus and Ebola virus. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 26:313–315.
   PubMedGoogle Scholar
• Yao J, Weng Y, Dickey A, Wang KY. (2015). Plants as factories for human pharmaceuticals: applications and challenges. Int J Mol Sci. 16:28549–28565.
   PubMed Web of Science ®Google Scholar
• Ye L, Yang C. 2015. Development of vaccines for prevention of Ebola virus infection. Microbes Infect. 17:98–108.
   PubMed Web of Science ®Google Scholar
• Zaki SR, Shieh WJ, Greer PW, Goldsmith CS, Ferebee T, Katshitshi J, Tshioko FK, Bwaka MA, Swanepoel R, Calain P, et al. 1999. A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Commission de Luttecontre les Epidémies à Kikwit. J Infect Dis. 179:S36–S47.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang H. 2014. Forty years of the war against Ebola. J Zhejiang Univ Sci B. 15:761–765.
   PubMed Web of Science ®Google Scholar
• Zhang XA, Li S, Ching J, Feng HY, Yang K, Dolinger DL, Zhang LD, Zhang PH, Liu W, Cao WC. 2017. A sensitive and specific point-of-care detection assay for Zaire Ebola virus. Emerg Microbes Infect. 6:e5. doi: 10.1038/emi.2016.134.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li D, Jin X, Huang Z. 2014. Fighting Ebola with ZMapp: spotlight on plant-made antibody. Sci China Life Sci. 57:987–988.
   PubMed Web of Science ®Google Scholar
• van Griensven J, De Weiggheleire A, Delamou A, Smith PG, Edwards T, Vandekerckhove P, Bah EI, Colebunders R, Herve I, Lazaygues C, et al. 2015. The use of Ebola convalescent plasma to treat Ebola virus disease in resource-constrained set-tings: a perspective from the field. Clin Infect Dis. 62:69–74.
   PubMed Web of Science ®Google Scholar